Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cytokinetics Inc. buy JPMorgan Chase & Co.

Cytokinetics Inc.
Start price
€54.00
20.01.26 / 50%
Target price
€63.57
20.01.27
Performance (%)
3.70%
Price
€56.00
13.02.26
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 3.70%. This prediction currently runs until 20.01.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Cytokinetics Inc. 5.660%
iShares Core DAX® 0.463%
iShares Nasdaq 100 -1.792%
iShares Nikkei 225® 5.124%
iShares S&P 500 -1.760%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Discuss Cytokinetics Inc.
Prediction Buy
Perf. (%) 3.70%
Target price 63.566
Change
Ends at 20.01.27

Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at JPMorgan Chase & Co. from $70.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
20.01.26

Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€29.00
09.06.25
€46.41
09.06.26
93.10%
13.02.26

JPMorgan Chase & Co. 
09.06.25 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€50.50
05.09.24
€63.96
05.09.25
-9.31%
06.09.25

JPMorgan Chase & Co. 
05.09.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€49.60
24.06.24
€60.52
24.06.25
-42.74%
25.06.25

JPMorgan Chase & Co. 
24.06.24 50%